Seeking Alpha

Cepheid (CPHD +4.8%) gets a boost from a Goldman upgrade to buy, noting the company's new...

Cepheid (CPHD +4.8%) gets a boost from a Goldman upgrade to buy, noting the company's new product opportunities, increased global TB testing, and improved top-line growth.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs